Certara introduces Simcyp Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development

21.11.2023 - Simcyp Biopharmaceutics helps drug developers replace costly clinical bioequivalence studies and optimize formulations for complex therapiesPRINCETON, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) - Certara, Inc. (Nasdaq: CERT), a global leader in ...

Related Keywords

Ariane Lovell ,Sheila Rocchio ,Simcyp Biopharmaceutics ,Rob Aspbury ,Certara Scientific Software ,Simcyp Simulator ,Certara Scientific ,Costly Clinical Bioequivalence Studies ,Complex Drugs ,Biopharmaceutical Classification System ,Drug Labels ,Certara Chart ,Ertara Kurs ,Ertara Aktie ,